Scleroderma, Systemic: all 695 studies
Page 5 of 7. Open to participants first (224), then studies with results posted, then the rest; newest registration first within each.
- A Study of MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)TerminatedNCT04948554Phase 1
- Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)Active, not recruitingNCT04927390Phase 2
- Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin DiseasesActive, not recruitingNCT04922736Not applicable
- Systemic Sclerosis' Relatives ReflexCompletedNCT04917146
- RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and FatigueCompletedNCT04908943Not applicable
- Effect of Ozone Therapy for the Treatment of Digital Ulcer in Patients With SScCompletedNCT04826419Not applicable
- Immunomodulating Effects of Supplementation With 25-OH Vitamin DCompletedNCT04822038Not applicable
- Study of the Intestinal Microbiota of Patients With Systemic SclerosisStatus unknownNCT04791280
- The Influence of Extracorporeal Photopheresis on Skin SclerosisCompletedNCT04752397
- Autologous Fat Grafting in the Treatment of Critical Limb IschaemiaStatus unknownNCT04746599Not applicable
- Prevalence of Hyperprolactinemia in Systemic SclerodermaCompletedNCT04746313
- Clinical Relevance of Thoracic Echography for the Early Diagnosis of Interstitial Lung Disease in Systemic Scleroderma - Pilot StudyCompletedNCT04725786Not applicable
- Telerehabilitation on Hand-Affected SclerodermaCompletedNCT04684225Not applicable
- Effects of a Supervised Exercise Program and a Home Exercise Program in Patients With Systemic SclerosisCompletedNCT04675502Not applicable
- Functional Exercise Tests in Patients With Systemic SclerosisStatus unknownNCT04650659
- Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal DiseaseStatus unknownNCT04630782
- Feasibility and Preliminary Effects of the Resilience-based, Energy Management to Enhance Wellbeing in Systemic Sclerosis (RENEW) InterventionCompletedNCT04588714Not applicable
- Effectiveness of Telerehabilitation on SclerodermaStatus unknownNCT04563481Not applicable
- Optical Coherence Tomography Imaging in Systemic SclerosisCompletedNCT04532151Not applicable
- The Effects of Botulinum Toxin on Oral Aperture in Patients With SclerodermaCompletedNCT04523506Early Phase 1
- Iguratimod in Systemic SclerosisStatus unknownNCT04515706Not applicable
- Utility of Breath-holding Test in Systemic SclerosisCompletedNCT04484948Not applicable
- Effectiveness of a Home-based, Self-administered Exercise Program for Hands in Patients With Systemic SclerosisCompletedNCT04481984Not applicable
- Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic SclerosisCompletedNCT04464434Phase 4
- Effects of Fibromyalgia Syndrome in Patients With Systemic SclerosisCompletedNCT04411498
- Online Fatigue Intervention Program for People With SclerodermaCompletedNCT04401943Not applicable
- Safety Of Fat Micrografts With Adipose-Derived Stromal Vascular Fraction In Hands Of Patients With Systemic SclerosisCompletedNCT04387825Phase 2
- TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic SclerosisActive, not recruitingNCT04380831Early Phase 1
- A Study of KHK4827 in Patients With Systemic SclerosisCompletedNCT04368403Phase 1
- Is a History of Pre-eclampsia a Risk Factor for Vascular Phenotype in Women With Systemic Sclerosis?CompletedNCT04363021
- Screening Patients With Diabetes Mellitus for the Presence of Skin Disorder of ScleredemaStatus unknownNCT04335396
- Sirtuin 3 and Sirtuin 7 in Systemic SclerosisStatus unknownNCT04303208Not applicable
- Assessment of Nutritional Status in Systemic SclerosisCompletedNCT04301596
- Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue)CompletedNCT04300426Phase 2
- A Study of the Efficacy and Safety of Rituximab in Participants With Systemic SclerosisCompletedNCT04274257Phase 2/3
- Mouth Handicap in Systemic SclerosisCompletedNCT04273386Not applicable
- Adult-onset Generalized MorpheaStatus unknownNCT04264728
- SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF)CompletedNCT04246528Not applicable
- MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic SclerosisTerminatedNCT04244916
- 7.0 Tesla Resonance Magnetic Imaging of the Hand in Systemic SclerosisCompletedNCT04223817Not applicable
- IgG-4 Levels in Systemic SclerosisCompletedNCT04219592
- Effectiveness of Tai Chi Exercise Program in Scleroderma PatientsCompletedNCT04214925Not applicable
- Trial on Outpatients With Systemic Sclerosis Treated With Well-Being Therapy or With a Control TherapyCompletedNCT04212247Not applicable
- Systemic Sclerosis and Jak Inhibitors : Emphasis on MacrophagesActive, not recruitingNCT04206644
- Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized SclerodermaCompletedNCT04200755Phase 2
- The Effect of Physiotherapy Program in Scleroderma PatientsCompletedNCT04179292Not applicable
- Assessment of the Prevalence of Olfactory Disorders in Systemic SclerodermaTerminatedNCT04178616Not applicable
- Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic SclerosisSuspendedNCT04166552Phase 2
- microRNAs in Systemic SclerodermaCompletedNCT04148716
- Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)WithdrawnNCT04138485Phase 2
- Muscular Respiratory Involvement and Systemic SclerosisCompletedNCT04118725Not applicable
- Vitamin D in Systemic Sclerosis Patients With PeriodontitisCompletedNCT04066842
- The Benefit of Bermekimab in Patients With Systemic SclerosisCompletedNCT04045743Phase 2
- RElevance of UltraSonography for Assessing Salivary Gland Involvement in Systemic Sclerosis (SSc)CompletedNCT04001556Not applicable
- The SPIN - Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED)CompletedNCT03965780Not applicable
- A Phase 3 Study of KHK4827 in Patients With Systemic SclerosisCompletedNCT03957681Phase 3
- Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
- Objective Measurement Methods for Autoimmune Disease and Dry Eye SyndromeWithdrawnNCT03937271
- SPIN Self-Management Feasibility TrialCompletedNCT03914781Not applicable
- A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic SclerosisCompletedNCT03889509
- Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017Status unknownNCT03858842
- Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung DiseaseStatus unknownNCT03856853Phase 3
- Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic SclerosisActive, not recruitingNCT03844061Phase 2
- Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic SclerosisCompletedNCT03831438Phase 1
- Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)Status unknownNCT03819777
- A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and DermatomyositisCompletedNCT03817424Phase 1
- Role of Eosinophil in Fibrogenesis of Systemic SclerosisCompletedNCT03816189
- A Comparison Between Two Educational Methods in the Rehabilitation of the Microstomia in Systemic SclerosisCompletedNCT03766243Not applicable
- Cell Surface Marker Expression in Autoimmune DiseasesCompletedNCT03757065
- Local Injection of Ozone Versus Methylprednisolone Acetate in Carpal Tunnel Syndrome of Scleroderma PatientsCompletedNCT03742466Not applicable
- CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PHWithdrawnNCT03726398Phase 2/3
- Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic SclerosisCompletedNCT03717961Phase 3
- Prednisolone in Early Diffuse Systemic SclerosisCompletedNCT03708718Phase 2
- Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic SclerosisCompletedNCT03692299Phase 4
- Mycophenolate Mofetil Pharmacokinetics in Systemic SclerosisCompletedNCT03678987
- Suction Based Characterization of Healthy and Diseased SkinCompletedNCT03644225Not applicable
- BIOLOGICAL EXPLORATION OF THE VASCULAR FRACTION FROM THE ADIPOSE TISSUE OF PATIENTS WITH SCLERODERMIAStatus unknownNCT03629002
- Individualized Home-based Exercise Program for Patient With Systemic Sclerosis.CompletedNCT03614208Not applicable
- Pragmatic Clinical Trials in SclerodermaStatus unknownNCT03610217Not applicable
- Mechanisms of Pulmonary Diffusion Limitation in Systemic SclerosisCompletedNCT03601520
- The Small Intestine Bacterial Overgrowth Study PilotStatus unknownNCT03588845Not applicable
- Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic SclerosisCompletedNCT03575156Not applicable
- Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic SclerosisCompletedNCT03561233Phase 1
- Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.CompletedNCT03559465Not applicable
- Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma PatientsCompletedNCT03558854Phase 4
- Professional and Personal Toxic Exposure in Systemic Sclerosis : Type, Intensity and Probability of ExpositionCompletedNCT03543956
- Analysis of Cytokine Expression Pattern in Systemic SclerosisCompletedNCT03537105Not applicable
- Topical Rosemary Oil Application in Systemic SclerosisCompletedNCT03531216Not applicable
- Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic SclerosisStatus unknownNCT03508375Not applicable
- Rehabilitation for Arm Coordination and Hand Movement in Systemic SclerosisCompletedNCT03482219Not applicable
- Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary HypertensionStatus unknownNCT03459716
- Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE)Status unknownNCT03446339
- Gut Microbiota Transplantation in Systemic SclerosisCompletedNCT03444220Phase 1/2
- Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILDCompletedNCT03438032
- Yellow Fever Vaccine in Patients With Rheumatic DiseasesCompletedNCT03430388Not applicable
- Scleroderma Patient-centered Intervention Network (SPIN) Hand ProgramCompletedNCT03419208Not applicable
- Mindfulness Based Stress Reduction in Rheumatic DiseasesTerminatedNCT03411057
- Autologous Adipose Tissue in the Treatment of Systemic Sclerosis Digital UlcersStatus unknownNCT03406988Not applicable
- Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic SclerosisTerminatedNCT03398837Phase 3
- Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma DiseasesTerminatedNCT03388255Phase 4